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Background: Dexmedetomidine (dex) is commonly used in intensive care due to its effec-
tive sedation and analgesia with few adverse effects and minimal respiratory depression.
However, we recently observed that exposing mouse epithelial respiratory cells to dex
decreased ciliary beat frequency (CBF), suggesting dex may pose pulmonary risk.
Objective:The purpose of this study is to determine the effects of dex at clinically relevant
doses on CBF in human respiratory epithelia.
Methods: Human nasal epithelial cilia were obtained from the inferior nasal turbinate
with a rhinoprobe and placed in culture medium at 15°C and 37°C. At 5 and 30 min,
video-microscopy was used to assess CBF, either without (control) or with different
concentrations (1, 5, and 10 nM) of dex, fentanyl (fen), and dex+ fen combination.
Results: At 15°C, CBF was lower in the dex group compared to controls at 5 and 30 min.
At 37°C, there was a significant increase in CBF with dex at 5 and 30 min, except for
dex at 5 nM after 5 min, which showed a significant decrease. At 15°C the combination
of dex+ fen showed a positive interaction, causing less ciliary inhibition as expected. In
contrast, no interaction between drugs was seen between dex and fen at 37°C.
Conclusion: At low temperatures, dex reduces CBF in human respiratory epithelia,
whereas dex increases CBF at physiologic temperature in vitro. Whether these effects
translate into clinical consequences during hypothermia, as with cardiopulmonary bypass
surgery will require further studies.
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INTRODUCTION
In intensive care medicine, physicians face the challenge of provid-
ing effective sedation while minimizing adverse effects. Sedatives
are necessary to provide patient comfort and safety, but their
administration must be weighed against deleterious consequences.
Dexmedetomidine (dex), an alpha-2 agonist, is being increasingly
used due to its effective sedative property (1). This has made dex
appealing in cardiac intensive care,where hemodynamic instability
warrants medications that minimally compromise cardiovascu-
lar and respiratory function, especially during postsurgical care
after cardiopulmonary bypass surgery (CBP) (2, 3). However, we
recently obtained data from in vitro studies of the mouse respira-
tory epithelia showing dex decreased ciliary beat frequency (CBF),
an objective measure of ciliary motility, thereby raising concerns
about dex compromising lung clearance function. CBF plays an
essential role in propelling mucus and foreign particles out of the
airways. Although studies have identified a multitude of factors
that can depress CBF, including anesthetics and hypothermia, the
effects of dex on human respiratory epithelia have not been specif-
ically examined (4–6). Therefore, we undertook the present study
to determine the effects of dex on ciliary motility at 15°C and 37°C
in humans.
MATERIALS AND METHODS
OBTAINING HUMAN RESPIRATORY EPITHELIA
This study was approved by the University of Pittsburgh Internal
Review Board. Informed consent was obtained from all volunteers.
Human nasal epithelial cells from 10 adult volunteers were col-
lected with a rhinoprobe curette (Arlington Scientific, Springville,
UT, USA) using a nasal speculum. The curette was gently scraped
three times over the surface of each inferior nasal turbinate and the
tissue was immediately placed in 5 ml RPMI-1640 culture medium
(Leibowitz-15 medium) at room temperature. Tissue obtained
from one person was used as a single sample.
PROCESSING OF HUMAN RESPIRATORY EPITHELIA AND PREPARATION
OF CELL GROUPS
Samples from the same individual were placed in media precooled
or heated at 15 or 37°C, immediately after extracting the samples
from healthy volunteers. Video-microscopy was performed 5 and
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30 min after placing the cells in the media, and CBF calculated from
these videos. Media contained either no drug (control group), or
an anesthetic drug at 1, 5, and 10 nM concentration comprising:
(a) dex, (b) fentanyl (fen), or (c) dex+ fen combination. These
concentrations are equivalent to therapeutic plasma concentra-
tions achieved during the course of routine clinical care (7, 8). To
ensure similar sampling from each subject for each condition, tis-
sue from five different volunteers was obtained and tested across
all conditions for a total of 1991 data points.
MEASUREMENT OF CILIARY BEAT FREQUENCY
Ciliary motion was recorded with a Leica DMIRE2 inverted micro-
scope (Leica Microsystems, Buffalo Grove, IL, USA) using a 100×
differential interference contrast (DIC) oil objective under DIC
optics. To achieve a constant temperature of 15°C, the microscope
was placed in a room with an adjusted temperature of 15°C. For
37°C, the microscopy was conducted with a heated objective main-
tained at 37°C (Bioptechs, Butler, PA, USA). Videos were captured
at 200 frames/s with a Phantom v4.2 high speed CMOS camera
(Vision Research, Wayne, NJ, USA). To measure CBF, at least four
videos were recorded for each condition. The videos obtained were
analyzed with ImageJ (NIH) to create a kymograph for measur-
ing the CBF. The CBF was measured from eight regions of interest
showing beating cilia per video and averaging five successive wave-
lengths per region using GIMP v2.6. Mean CBF was calculated
for the control group as well as for dex, fen, dex+ fen at both
temperatures and time points.
REAL TIME PCR ANALYSIS
Nasal tissue was placed in culture on rat tail collagen-coated plates
and media containing Ultroser G (Pall Corp.), and grown to con-
fluence. Once confluence was achieved, collagen was removed
using collagenase IV (Worthington Biochemicals, NJ, USA) and
cells placed in suspension on a 37°C orbital shaker. The nasal
epithelial cells lose their cilia as they grow on the collagen sub-
stratum, and when placed in suspension culture, they reciliate
within 10–14 days (9). Once reciliation was confirmed, RNA from
these cells was extracted using RNeasy Plus micro kit (Qiagen,
cat #74034), with generation of amplified cDNA (NuGen, Ova-
tion RNA-Seq System, cat #7102-32), and real time PCR (rt-PCR)
performed using primers specific for human alpha and beta-
adrenergic receptors as well as opioid receptors. We also isolated
nasal epithelial cells using a rhinoprobe to scrape the inferior
turbinate under direct visualization using a nasal speculum. Cells
were lysed using RNA lysis buffer (Qiagen), reverse transcrip-
tion performed to generate cDNA and rt-PCR performed on this
sample using the same primers as above for human alpha and
beta-adrenergic as well as opiod receptors. All expression levels
were normalized against human beta-actin gene.
STATISTICAL ANALYSIS
Differences in the mean CBF values between each drug category
and control and difference between two temperatures for each
drug or control were determined by heteroscedastic unpaired t -
tests. A multivariate linear regression model was constructed to
assess the main effect of the two drugs (dex and fen) and their
interaction effect, separately, for each temperature. At each tem-
perature, a regression model was fitted to the CBF data from the
three drugs with control as the reference group. The intercept in the
model is the estimated mean CBF for the control; the other positive
or negative regression coefficients represent estimated increases or
reductions in CBF for individual drugs and their interaction as
compared to the control. The mean effect of the drug concentra-
tions (1, 5, or 10 nM) and time of exposure to drug (5 or 30 min)
were also examined using the regression model. All tests were two-
tailed and p-values <0.05 were considered significant. Analyses
were performed with SAS 9.3 (SAS Institute, Cary, NC, USA).
RESULTS
In order to evaluate the effects of dex and fen on respiratory air-
way cilia, human nasal epithelial cells were obtained by curettage
of the inferior nasal turbinate under direct visualization video-
microscopy performed. Cells from 10 volunteers (6 male, 4 female,
median age 30) were obtained and a total of 1991 videos were
obtained for this study (Table S1 in Supplementary Material).
EFFECTS OF TEMPERATURE ON CILIARY BEAT FREQUENCY
We examined temperature effects on CBF at 15°C to mimic con-
ditions during CPB surgery and 37°C corresponding to body
temperature. The CBF was obtained with exposure to tempera-
ture and drugs at 5 and 30 min, with samples exposed to drugs
including dex, fen, and dex+ fen at 1, 5, and 10 nM drug con-
centrations (Figure 1). Mean CBF was significantly lower in all
FIGURE 1 | Processing of human respiratory epithelia and preparation
of cell groups.
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groups at 15 vs. 37°C at 5 and 30 min (Table S2 in Supplementary
Material).
EFFECTS OF DRUG EXPOSURE ON CILIARY BEAT FREQUENCY
At 15°C, exposure to drugs caused a reduction of CBF at all con-
centrations at 5 and 30 min. Figure 2 shows mean CBF for each
group (p< 0.05). When compared to controls, all drugs led to a
significant increase in CBF at 37°C, except for dex 5 nM at 5 min,
which decreased CBF significantly (Figure 3). This unexpected
cilia-depressant effect was no longer significant when the groups
of dex with 5 nM concentration at 5 and 30 min at 37°C were
pooled together and compared to controls.
DRUG–DRUG AND DRUG–TIME INTERACTION ON CILIARY BEAT
FREQUENCY
To investigate drug interactions between dex and fen, a multivari-
ate linear regression model was constructed separately for each
temperature. Although there are differences in CBF values under
different concentrations or drug exposure times for each given
drug, the average effect of drug concentration across the three
drugs was not significant in the regression models. The average
effect of drug exposure time was significant in the model at 37°C,
but not at 15°C. When using controls as reference, the combina-
tion of dex+ fen showed a positive interaction at 15°C, causing
less cilia inhibition than expected by summation of their individ-
ual effects. In contrast, no interaction was seen between dex and
fen at 37°C. Thus the estimated effect for dex+ fen group was
similar to the sum of the individual positive effects from dex and
fen (Table 1).
Multivariate linear regression model was also used to show
time effects on the CBF, as the analysis of variance did not show
effects between different concentrations in each group. Accord-
ingly, we pooled the data from different concentrations together
to generate larger sample sizes. The regression model showed no
significance for the effect of time at 15°C (p= 0.663). In contrast,
the time effect in the regression model was significant at 37°C
(p< 0.05, Table 2). The individual means for each group showed
a trend toward increased CBF at 30 min compared to 5 min for dex
(p= 0.089) and dex+ fen (p= 0.035).
ADRENERGIC AND OPIOID RECEPTOR TRANSCRIPT EXPRESSION IN
THE MOUSE AIRWAY EPITHELIA
To examine possible molecular mechanism for the drug–drug
interactions as well as drug–temperature and time effects of dex
FIGURE 2 | Effects of drug exposure on ciliary beat frequency at 15°C.
FIGURE 3 | Effects of drug exposure on ciliary beat frequency at 37°C.
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Table 1 | Drug–drug and Drug–time interaction on ciliary beat
frequency.
Variables 15°C (n=818) 37°C (n=1173)
Estimate (SE) p-value Estimate (SE) p-value
Intercept 3.64 (0.11) <0.0001 10.51 (0.30) <0.0001
Fen −0.76 (0.13) <0.0001 0.28 (0.32) 0.37
Dex −0.67 (0.13) <0.0001 0.43 (0.33) 0.19
Dex and fen
interaction
0.60 (0.15) <0.0001 0.20 (0.37) 0.59
Drug exposure
time (30 vs. 5 min)
– – 0.31(0.14) 0.023
Table 2 | Multivariate regression model at 37°C.
Mean CBF in
Hz±SD
Control Dex Fen Dex+ fen
At 5 min 10.82±1.71 10.82±2.93 10.88±2.25 11.35±2.16
At 30 min 10.42±2.26 11.39±2.65 11.00±2.13 11.81±2.09
p-value 0.45 0.089 0.58 0.035
and fen, we investigated expression of adrenergic and opioid recep-
tor subtypes in reciliated human nasal epithelia with rt-PCR.
Quantitative PCR showed high level of adrenergic beta-2 recep-
tor expression followed by beta-1 receptors, without detectable
expression of alpha-adrenergic or opioid receptors (Figure S1
in Supplementary Material). Quantitative PCR results carried
out on freshly isolated nasal epithelial cells showed high levels
of beta-adrenergic receptor expression (beta-1> beta-2), with-
out detectable alpha-adrenergic or opioid receptors, similar to our
findings from the quantitative PCR carried out on the reciliating
tissue.
DISCUSSION
In the intensive care setting, administration of anesthetic agents
requires a thorough understanding of their pharmacodynamics
and adverse effects. Dex, an alpha-2 agonist, has been exten-
sively used for sedation and analgesia due to its favorable safety
profile (10, 11). In a recent animal study, we found significant
cilia-inhibitory effect with dex at 10 nM at 22–24 and 37°C, but
no significant effect at 15°C (12). The cilia-inhibitory effect of
dex was reversed by combining dex with fen, which by itself
was cilia-stimulatory at all temperatures. Conversely, a Japanese
study found no effect of dex at 10 and 100 nM on CBF using
cultivated rat tracheal epithelial cells at 26.5°C (13). Given these
conflicting results and lack of human studies, we investigated
the effects of dex on cilia motility using human nasal epithelial
cells.
Nasal epithelial cells are known to be satisfactory surrogates of
tracheal and bronchial epithelial cells (14) and therefore bronchial
muco-ciliary clearance (15). The CBF has proven to be strongly
correlated with the efficacy of mucus transport, with a non-linear
relationship noted such that even slight reductions in CBF can
translate into significant impairment in muco-ciliary transport
(15). To interrogate the effects of the various drugs on CBF, we
used concentrations equivalent to therapeutic doses and exam-
ined all samples at physiological temperature and at 15°C, the
latter to simulate hypothermia during CPB surgery. We added fen
to replicate our mouse study. After exposing human respiratory
epithelial cells to dex, fen, and dex+ fen, we found a significant
cilia-stimulatory effect at 37°C, but a significant cilia-inhibitory
effect at 15°C with all drugs. This suggests that administration of
dex at physiologic temperatures would not cause cilia inhibition.
This finding is important because this drug is mainly adminis-
tered in critically ill patients who frequently have abolished airway
reflexes, and are predisposed to pulmonary morbidity. Our finding
of a cilia-inhibitory effect at low temperatures would suggest these
drugs might have unfavorable effects in hypothermic patients,
such as those undergoing CPB surgery. If cilia motility can be
restored with re-warming the patient, such risks may be minimal.
Further studies are needed to examine the reversibility of the low
temperature effects.
We did not find significant correlation between drug con-
centration and CBF (e.g., higher concentrations did not cause
a greater magnitude change in CBF). Furthermore, no signifi-
cant changes in CBF over time were observed at 15°C (e.g., no
differences between 5 and 30 min). This suggests that dex and
fen does not produce progressively more depressive effects over
time with drug exposure in hypothermia. In contrast, there was a
significant time effect with drug exposure at 37°C. Longer expo-
sure with dex or dex+ fen led to higher CBF, whereas fen alone
showed no difference. This suggests dex enhances CBF over time
with drug exposure at 37°C. However, as these agents are given
over longer periods for sedation purposes both at 15 and 37°C,
the long-term effect on CBF remains unknown and requires fur-
ther studies. There were significant drug interactions between
dex and fen at 15°C. This was indicated by our linear regres-
sion modeling, which showed non-additive effects, with less CBF
inhibition observed then would be expected by summation of
the individual drug effects. These findings suggest there may
be overlap in the mechanisms of CBF regulation by drugs and
temperature.
POSSIBLE MECHANISM FOR EFFECTS OF DEX AND FEN ON CBF
The cilia-inhibitory effects of dex and fen were significant at low
temperatures, whereas we found a significant trend toward cilia-
stimulation at 37°C (except for dex 5 nm at 5 min). Temperature
augments CBF in a sigmoid fashion, from cilia stasis below 10°C
to a near optimal rate at 32°C (16). Low temperatures have been
shown to inhibit adenyl cyclase activity, reduce cAMP concentra-
tions and alter PKC and CAMKII activity in ciliated cells (17, 18).
Studies have shown alterations in adrenergic and opioid receptor
affinity in response to different agonists during hypothermia (17).
Hypothermia may favor receptor affinity and second messenger
profile that potentiates the individual and combined effects of dex
and fen, thus producing synergistic cilia inhibition between drugs
and temperature. In contrast, higher temperatures may produce a
receptor affinity/second messenger configuration that might have
opposing effects on CBF (19).
While our rt-PCR analysis did not detect expression of alpha-
adrenergic receptors in reciliating human airway epithelia, we
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have observed low-level expression of alpha-2 adrenergic recep-
tor transcripts in RNA-seq analysis of whole human respiratory
epithelia obtained from nasal scrapes (M. Zahid and C. Lo, unpub-
lished observations). This would suggest dex could act through
the alpha-2 adrenergic receptor to modulate CBF in the human
respiratory epithelia. The classical alpha-2 pathway is known to
cause Gi-mediated adenyl cyclase inhibition, which would cause
reductions in cAMP levels and intracellular calcium (20). How-
ever, as the transcript abundance was low, the effects of dex may
involve another pathway. It is reported that dex blocks muscarinic
subtype 3 receptor in Xenopus oocytes and inhibits intracellular
calcium elevation (21), but these results have not been described
in human cells. Several studies have shown fen is antagonistic
to the muscarinic 3 receptor (22–24). An alternative explana-
tion is that these drugs could act through a different cell type
not present in the reciliating respiratory epithelia used for our rt-
PCR analysis. These cells may modulate CBF in the intact human
respiratory epithelia via transmission of ions and/or second mes-
sengers by gap junction mediated cell–cell communication (25,
26). This also could account for the previous report that dex and
fen did not alter CBF in cultured reciliated respiratory epithelial
cells (13).
LIMITATIONS
We note the ciliated respiratory epithelia used for our analysis were
removed from autonomic neural signaling and vascular supply,
both of which are known to regulate CBF in vivo and are affected
by dex (16). To maximize potential clinical relevance, drug con-
centrations used in this study were equivalent to therapeutic doses
and all samples were examined at physiologic temperature and
conditions mimicking hypothermia during CPB. Further studies
are needed to evaluate the effect of dex in vivo. As clinical outcomes
were not examined in this study, our results should be considered
hypothesis generating and further studies are needed to see how
these in vitro observations of the effects of dex on CBF translate
into being clinically relevant.
CONCLUSION
Nasal epithelial cells are known to be satisfactory surrogates of
tracheal and bronchial epithelial cells. In the present study, we
found that dex and fen are cilia-inhibitory at 15°C, and have cilia-
stimulatory effects on CBF at physiologic temperatures. Increasing
dose and combining both agents with exposure up to 30 min did
not produce additional changes in CBF. Combination of dex+ fen
showed positive interaction, causing less cilia inhibition at 15°C.
In contrast, no interaction between dex and fen was observed at
37°C. Whether these effects translate into clinical consequences
during hypothermia, as with CBP surgery, or if this can be reversed
upon temperature normalization, will require further studies. In
addition, further studies are needed to delineate the receptors
and second messengers regulating cilia motility in the human
respiratory epithelia and the mechanism by which dex and fen
modulates CBF.
SUPPLEMENTARY MATERIAL
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